openPR Logo
Press release

Global Market for Influenza Antiviral to Witness Considerable Upsurge During 2018 - 2028

09-20-2018 12:24 PM CET | Health & Medicine

Press release from: Future Market Insights

Global Market for Influenza Antiviral to Witness Considerable

Influenza is a viral disease having the same symptoms as most of the flus, such as fever, chills, cough, pain, sore throat, etc. Influenza antiviral drugs make the most effective and safe treatment option for this flu and are available in the form of pills, inhalers, oral suspension and injectables. These drugs are sold only with a prescription and are not available over the counter. Influenza antiviral drugs make flu symptoms milder and reduce the duration of illness. However, they do not eliminate the risk of complications, which include bacterial infections, pneumonia, organ system abnormalities, etc. Oseltamivir, Zanamivir and Peramivir are the most preferred drugs, which are effective against both influenza A and B viruses. These commercially approved influenza antiviral drugs also have several side effects, such as nausea, vomiting, diarrhoea and certain behavioural changes. The drugs are available to be used for children, adults as well as old people.
Request For Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7031

Influenza outbreaks usually happen every year and may reach epidemic levels during some seasons. Influenza antiviral drugs create a huge healthcare burden globally each year. According to CDC, there have been between 9.2 million and 35.6 million cases, between 140,000 and 710,000 hospitalization cases and between 12,000 and 56,000 deaths annually, since 2010, in the U.S.

Influenza Antiviral Market: Drivers & Restraints

Ongoing R&D, increasing demand for government stockpiling and strong R&D focus will fuel the growth of the influenza antiviral drugs market. Launching of generic versions of branded products will also promote the growth of the influenza antiviral market. For instance, the generic version of Tamiflu antiviral drug was released in 2016 and has affected the Influenza Antiviral Market positively. Adoption of influenza vaccination is also a restraint to the growth of the influenza antiviral market. Unmet medical needs in certain global regions will also limit the market growth of the influenza antiviral market.

Influenza Antiviral Market: Segmentation

The Influenza Antiviral Market can be segmented on the basis of drug type, dosage form and distribution channel.

Segmentation of Influenza Antiviral Marketby Drug Type

Oseltamivir
Zanamivir
Peramivir
Adamantanes
Other
Segmentation of Influenza Antiviral Marketby Dosage Form

Oral
Inhalation
Intravenous
Segmentation of Influenza Antiviral Marketby Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Influenza Antiviral Market: Overview

Mergers and collaborations among the market players for R&D, product manufacturing and marketing will play an important role in the growth of theInfluenza Antiviral Market. Influenza is a seasonal outbreak and thus, the market for its drugs is also expected to grow during the outbreaks. Currently marketed influenza antiviral medications are approximately 70% to 90% effective in preventing influenza. Several studies for the available drugs have also proved their efficacy in children as well as adults. According to CDC, there are currently no major market shortages of influenza antiviral medications. Resistance associated with the currently marketed drugs might generate the need for the development of novel medications. Also, there exists variations in the working of antiviral drugs, depending on the influenza strain of influenza. Several new findings are still going on to develop safe and effective influenza antiviral drugs. New drugs are anticipated to get approved and marketed in the next few years, which will provide physicians with more options for the treatment and prevention of the disease.

Influenza Antiviral Market: Region-wise Outlook

Geographically, North America holds the largest share in the influenza antiviral market owing to the high prevalence of influenza in the region and the favorable reimbursement scenario in the region. North America is followed by the Western Europe market due to easy access to healthcare facilities and governmental support for the control on the spread of contagious diseases. The Asia-Pacific market is also anticipated to expand at a significant growth rate over the forecast period due to the improving healthcare facilities and increasing accessibility to disease diagnosis. China and India are the countries with highest growth rate in the region. Latin America followed by MEA represents the lowest market share due to inaccessibility to healthcare facilities in the region. However, various kinds of governmental and non-governmental support is available in the region, which will drive the growth of the market.

Request For Report Table of Content (TOC): https://www.futuremarketinsights.com/toc/rep-gb-7031

Influenza Antiviral Market: Key Players

Some of the market participants identified across the value chain of the Influenza Antiviral market are F. Hoffmann-La Roche Ltd., Cipla Limited, NATCO Pharma Limited, Seqirus USA Inc., GlaxoSmithKline Pharmaceuticals Ltd, Endo Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Adamas Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG and others.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India.
FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web: https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Market for Influenza Antiviral to Witness Considerable Upsurge During 2018 - 2028 here

News-ID: 1251296 • Views:

More Releases from Future Market Insights

Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Million by 2032
Global Lithium Ion Battery Separator Market Projected to Reach US$ 3,256.7 Milli …
The lithium-ion battery separator is a critical component in lithium-ion batteries, responsible for preventing short circuits and ensuring safe and efficient battery performance. It acts as a physical barrier between the positive and negative electrodes, allowing lithium ions to pass through while blocking the flow of electrons. With advancements in separator technology, these separators play a key role in enhancing battery capacity, cycle life, and overall safety in various applications,
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolstered by a Robust 7.1% CAGR from 2022
Industrial Drums Market on a Trajectory to Reach US$ 17.6 Billion by 2027, Bolst …
The Industrial Drums Market is experiencing a steady and promising trajectory, with an estimated value of US$ 12.5 billion in 2022, projected to escalate to US$ 17.6 billion by 2027 at a commendable Compound Annual Growth Rate (CAGR) of 7.1%. This growth is substantiated by a 6.6% CAGR in volume during 2022-27, as per Future Market Insights. Anticipated to expand 1.5 times within this period, the market presents alluring prospects for industry
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of the Metal Cans Industry, Catering to Health-conscious and Environmentally-aware Consumers
Supermarkets, Convenience Stores, and Eco-friendly Choices Fuel the Expansion of …
The metal cans market is predicted to grow at a CAGR of 5% over the forecast period, according to research by Future Market Insights. The industry's estimated value is expected to increase from US$ 56 Bn in 2023 to US$ 91.1 Bn by 2033. The market for metal cans has been driven by the heightened demand for the product in food and beverages industry. Metal cans helps prolong shelf-life of perishable
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 with a 4.8% CAGR
Folding IBCs Market Poised for Growth: Expected to Reach US$ 528 Million by 2027 …
The folding intermediate bulk containers (IBCs) market is on a growth trajectory, with an estimated value of US$ 418 million in 2022, projected to reach US$ 528 million by 2027, showcasing a Compound Annual Growth Rate (CAGR) of 4.8%. Remarkably, the China folding IBCs market defied initial pandemic-related skepticism and is anticipated to grow by 6.9% year on year in 2022. Despite global challenges, China's folding IBCs market is poised to contribute

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about